STAT3 and neoplasm: On the other hand, the mutation-driven excessive STAT3 activity in NK cells from patients with chronic lymphoproliferative disorders of NK cells, T-cell large granular lymphocytic leukemias [180], and NK/T-cell lymphomas of the nasal type [181] promotes lymphomagenesis and provides a tumor-promoting TME.